RobinCar2
Performs robust estimation and inference when using covariate adjustment and/or covariate-adaptive randomization in randomized controlled trials. This package is trimmed to reduce the dependencies and validated to be used across industry. See "FDA's final guidance on covariate adjustment"<https://www.regulations.gov/docket/FDA-2019-D-0934>, Tsiatis (2008) <doi:10.1002/sim.3113>, Bugni et al. (2018) <doi:10.1080/01621459.2017.1375934>, Ye, Shao, Yi, and Zhao (2023)<doi:10.1080/01621459.2022.2049278>, Ye, Shao, and Yi (2022)<doi:10.1093/biomet/asab015>, Rosenblum and van der Laan (2010)<doi:10.2202/1557-4679.1138>, Wang et al. (2021)<doi:10.1080/01621459.2021.1981338>, Ye, Bannick, Yi, and Shao (2023)<doi:10.1080/24754269.2023.2205802>, and Bannick, Shao, Liu, Du, Yi, and Ye (2024)<doi:10.48550/arXiv.2306.10213>.
- Covariate adjustment for two‐sample treatment comparisons in randomized clinical trials: A principled yet flexible approach
- Inference on the average treatment effect under minimization and other covariate-adaptive randomization methods
- Inference Under Covariate-Adaptive Randomization
- Model-Robust Inference for Clinical Trials that Improve Precision by Stratified Randomization and Covariate Adjustment
- Robust variance estimation for covariate-adjusted unconditional treatment effect in randomized clinical trials with binary outcomes
- Simple, efficient estimators of treatment effects in randomized trials using generalized linear models to leverage baseline variables
- Toward Better Practice of Covariate Adjustment in Analyzing Randomized Clinical Trials
This page was built for software: RobinCar2
